In conclusion, we show that expression of CD44 isoforms containing exon v6 in the presence of activated STAT3 and P38, increase cell survival in response to cisplatin treatment in GC cells and that these cells override CD44v6-negative cells after cisplatin treatment. The gene discussed is CD44; the disease is gastric cancer.